THYROID CANCER2008 - 2012

JOHNS HOPKINS HOSPITALCANCER REGISTRY

Prepared by Theresa SanLorenzo-Caswell, CTR09/02/2013

HEAD/NECK OF THE SKINANALYTIC vs. NON-ANALYTIC by YEARN = 1800

2008 2009 2010 2011 2012

ANALYTIC (1381) 207 243 295 294 340

NON-ANALYTIC (182) 37 40 40 34 32

25

75

125

175

225

275

325

375

NU

MBE

R

THYROID CANCER2008-2012 ALL CASES = 1562ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKINAGE AT DIAGNOSIS, ALL CASESN = 1800

0 - 19 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 79 80+

MALE (431) 7 27 55 80 116 105 34 7

FEMALE (1130) 32 126 258 275 230 136 60 14

25

75

125

175

225

NU

MBE

RTHYROID CANCER2008-2012 ALL CASES = 1562 AGE AT DIAGNOSIS BY GENDER

THYROID CANCER2008-2012 ALL CASES = 1562GENDER BY YEAR

2008 2009 2010 2011 2012

MALE 64 73 80 105 109

FEMALE 180 210 255 223 263

25

75

125

175

225

275

NU

MBE

R

THYROID CANCER2008-2012 ALL CASES = 1562RACE/ETHNICITY BY GENDER

CAUCASIAN AFRICAN AMERI-CAN

HISPANIC OTHER

MALE 362 26 11 32

FEMALE 851 127 43 110

50

150

250

350

450

550

650

750

850

NU

MBE

R

THYROID CANCER2008-2012 ALL CASES = 1562STATE OF RESIDENCE AT DIAGNOSIS

MD60.3%

VA21.3%

PA6.3%

DE2.2%

WV2.0%

OUT OF COUNTRY1.2%

FL1.1%

NY1.1%

ALL OTHER STATES4.5%

THYROID CANCER2008-2012 ALL MARYLAND CASES = 942COUNTY OF RESIDENCE AT DIAGNOSIS

BALTIMORE CO.15.1%

MONTGOMERY CO.12.6%

BALTIMORE CITY12.0%

HOWARD CO.11.2%

ANNE ARUNDEL CO.10.9%

FREDERICK CO.10.0%

PRINCE GEORGES CO.4.9%

HARFORD CO.4.5%

ALL OTHER COUNTIES18.9%

THYROID CANCER2008-2012 ALL CASES = 1562BY HISTOLOGY

PAPILLARY CA91.6%

MEDULLARY CA3.4%

FOLLICULAR CA1.9% ALL OTHER HISTOLOGIES

3.2%

THYROID CANCER2008-2012 ALL ANALTYIC CASES = 1365AJCC STAGE BY GENDER

AJCC I AJCC II AJCC III AJCC IV AJCC UNK

MALE 228 28 55 51 2

FEMALE 809 36 85 70 1

50

150

250

350

450

550

650

750

850

NU

MBE

R

Excludes class 0: Diagnosed at JHH only; all treatment elsewhere

THYROID CANCER2008-2012 ANALYTIC CASES = 1365*AJCC STAGE

AJCC I75.9%

AJCC II4.8%

AJCC III10.2%

AJCC IV8.9% AJCC UNK

0.2%

*Excludes class 0: Diagnosed at JHH only; all treatment elsewhere

THYROID CANCER2008-2012 ANALYTIC CASES* TREATMENT BY STAGE

AJCC I (1037) AJCC II (64) AJCC III (140) AJCC IV (121)

Surgery 9.8 1.5 1.4 2.4

Radiation 0 1.5 0 3.3

Surgery & Radiation 0.7 0 0.7 0.8

Surgery & Hormone 63.3 53.1 32.9 16.5

Surgery, Radiation & Hormone 25.8 43.9 65.0 60.6

All Other Combinations 0.1 0 0 14.8

Not Treated 0.3 0 0 1.6

100% 100% 100% 100%

*Excludes class 0: Diagnosed at JHH only; all treatment elsewhere

THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (357) 1 0.9916 0.9775 0.9746 0.9718 0.9689

SEER (14645) 1 0.996 0.993 0.989 0.984 0.98

NCDB (49319) 1 0.997 0.993 0.989 0.985 0.981

75%

85%

95%

AJCC I

PERC

ENTA

GE

©2013 NCDB, CoC©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (37) 1 1 1 1 0.9722 0.9722

SEER (1811) 1 0.991 0.981 0.973 0.961 0.948

NCDB (7122) 1 0.993 0.986 0.979 0.968 0.957

93%

94%

95%

96%

97%

98%

99%

100%

AJCC II

PERC

ENTA

GE

©2013 NCDB, CoC©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (71) 1 1 1 0.9714 0.9714 0.9714

SEER (2169) 1 0.987 0.975 0.963 0.944 0.93

NCDB (8179) 1 0.983 0.972 0.957 0.941 0.927

89%

91%

93%

95%

97%

99%

AJCC III

PERC

ENTA

GE

©2013 NCDB, CoC©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (51) 1 0.7059 0.6657 0.6078 0.5294 0.5098

SEER (1762) 1 0.761 0.699 0.66 0.623 0.596

NCDB (5885) 1 0.776 0.714 0.672 0.635 0.598

5%15%25%35%45%55%65%75%85%95%

AJCC IV

PERC

ENTA

GE

©2013 NCDB, CoC©SEER; SEER*STAT